Pharmacists must sign the PGD to show their acceptance of the professional responsibilities contained in the PGD – supply is not legal until the PGD is signed.
IMPORTANT INFORMATION: CHANGE OF PROCESS – ELECTRONIC FORM RECORDING OF PGDs
Since April 2024, pharmacists have confirmed their acceptance of professional responsibilities for each Patient Group Direction (PGD) by completing our Microsoft electronic form.
Following a recent review, the Community Pharmacy Development Team (CPDT) recommended to the Area Pharmaceutical Committee (APC) and Community Pharmacy GGC that this additional confirmation step was no longer required. This recommendation was supported by both bodies and has now been approved by the NHS GGC PGD Group.
From 1 April 2026, the Microsoft form will be removed from the CPDT website, and pharmacists will no longer be required to complete it.
Pharmacists are covered under a PGD once they have accepted the professional obligations by signing the relevant authorisation sheet. There is no regulatory or legal requirement for copies of signed authorisation sheets to be submitted to NHS GGC or for confirmation of signing to be provided.
Contractors and pharmacists must continue to ensure that:
- Every pharmacist signs an individual copy of each PGD before undertaking the associated service; and
- Signed PGDs are retained within the pharmacy for 8 years from the effective date of the PGD for audit and governance purposes.
This change will not affect payment for any services provided under PGDs.
If you have any queries, please contact the Community Pharmacy Development Team at ggc.cpdevteam@nhs.scot
NATIONAL PGD
Unscheduled Care v32
- PGD Unscheduled Care v32 – exp Oct 2027
- Authorisation Form v32
- What’s New v32
- PGD v32 Medicines A-Z Look-up List
- Direct Referral – Prof to Prof contact numbers v32
NHS PHARMACY FIRST
- PGD Beclometasone 50μg Nasal Spray v1 – exp May 2026
- PGD Fexofenadine 120mg Tablets v1 – exp May 2026
- PGD Mometasone Furoate 50μg Nasal Spray v1 – exp May 2026
- PGD Nystatin Oral Suspension v1 – exp Oct 2026
- PGD Nystatin v1 – Supporting Information
- PGD Olopatadine 1mg/ml Eye Drops v1 – exp May 2026
- NHS PFS Hay Fever v1 Patient Assessment Form
Fusidic Acid, Nitrofurantoin, Trimethoprim v3
- PGD Fusidic Acid v 2% Cream v3 – exp Aug 2028
- PGD Nitrofurantoin v3 – exp Aug 2028
- PGD Trimethoprim v3 – exp Aug 2028
- NHS PFS Impetigo Patient Assessment Form v3
- NHS PFS UTI Patient Assessment Form v3
Aciclovir 800mg Tablets v2, Flucloxacillin v2
- PGD Aciclovir 800mg v2 – exp Feb 2027
- PGD Flucloxacillin v2 – exp Feb 2027
- NHS PFS Aciclovir Patient Assessment Form
- NHS PFS Flucloxacillin Patient Assessment Form
PUBLIC HEALTH
EHC v13
Progesterone Only Oral Contraception v2
- PHS Bridging Contraception Desogestrel PGD v2 – exp Sept 2027
- PHS Bridging Contraception Desogestrel PGD GP Notification Form v2
- PHS Combined EHC BC Assessment Form – Once for Scotland v1
- PHS Supporting guidance for EHC and Bridging Contraception v1
Varenicline – National PGD v1
- PGD Varenicline tablets, v1 – exp Apr 2028
- Assessment Form, v1
- NHS Circular – PCA(P)(2025) 06 – 10 Apr 2025
Amoxicillin v6, Doxycycline v6, Prednisolone v7
- PGD Amoxicillin v7 – exp Dec 2027
- PGD Doxycycline v7 – exp Dec 2027
- PGD Prednisolone v8 – exp Dec 2027
Inactivated Influenza Vaccine
- PGD Flu Vaccination v2.1 – exp Aug 2026
- PGD Flu Vaccination v2.1 – Single Signup Sheet – exp Aug 2026
Responsible Person: Lianne Hatch
Last Updated: 31/03/2026